Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-26-000122

Chief Executive Officer gave up 10,821 shares (to pay taxes)

  • Chief Executive Officer acquired 21,470 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kelderman Kim · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-08-15 Exercise or conversion : show line 1 in the form +21,470 93,583 D
2026-08-15 Shares withheld for taxes : show line 2 in the form −10,821 $72.40 $783,440 82,762 D

Table II: Derivative

8 lines
Date Transaction Shares Owned after D/I
2026-08-15 Exercise or conversion : show line 3 in the form Performance Restricted Stock Units −554 8,319 D
2026-08-15 Returned to the company : show line 4 in the form Performance Restricted Stock Units −8,319 0 D
2026-08-15 Returned to the company : show line 5 in the form Performance Stock Options (Right to Buy) −22,389 1,492 D
2026-08-15 Exercise or conversion : show line 6 in the form Performance Restricted Stock Units −588 8,835 D
2026-08-15 Returned to the company : show line 7 in the form Performance Restricted Stock Units −8,835 0 D
2026-08-15 Returned to the company : show line 8 in the form Performance Stock Options (Right to Buy) −24,324 1,621 D
2026-08-15 Exercise or conversion : show line 9 in the form Restricted Stock Units −8,543 8,544 D
2026-08-15 Exercise or conversion : show line 10 in the form Restricted Stock Units −11,785 23,569 D
Loading xslF345X06/form4.xml…